- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Gabitril
Synonyms :
Class :
Anticonvulsants; GABAnergic transmission enhancers
Dosage forms & Strengths:
Adult:
Tablet:
2 mg
4 mg
12 mg
16 mg
4 - 8
mg
Orally
every 8 hrs
1
week
Tablet
4
mg
Orally
every 12 hrs
1
week
Tablet
12 - 22
mg
Orally
every 12 hrs
1
week
Tablet
CNS depressants may increase the CNS depressant effect
may have an increased cns depressive effect when combined with zolpidem
may have an increased CNS depressant effect when combined with oxycodone
may have an increasingly adverse effect when combined with ropeginterferon alfa-2b
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
flunitrazepam: they may increase the CNS depressant effect of CNS Depressants
buprenorphine,long-acting injection
may increase the CNS depressant effect of Buprenorphine
may have an increased Effect of a CNS depressant when combined with blonanserin
may increase the risk of CNS depression when combined with 1,2-Benzodiazepine
hydroxyzine: they may increase the CNS depressant effect of CNS Depressants
methotrimeprazine: they may increase the CNS depressant effect of CNS Depressants
CYP3A strong enhancers of the small intestine may reduce the bioavailability of tiagabine
it increases the effect of CNS depressants
it increases the effect of CNS depressants
CNS depressants increase the effect of orphenadrine
it increases the effect of CNS depressants
it increases the efficacy of CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with orphenadrine
may have an increased CNS depressive effect when combined with paraldehyde
may have an increased CNS depressive effect when combined with thalidomide
it increases the effect of CNS depressants
may have an increased CNS depressant effect when combined with flunarizine
azelastine: they may increase the CNS depressant effect of CNS Depressants
olopatadine (Nasal): they may increase the CNS depressant effect of CNS Depressants
azelaic acid: they may increase the CNS depressant effect of CNS Depressants
ipratropium: they may increase the CNS depressant effect of CNS Depressants
naltrexone: they may increase the CNS depressant effect of CNS Depressants
may enhance the adverse/toxic effect of antipsychotic agents
may enhance the adverse/toxic effect of antipsychotic agents
may enhance the adverse/toxic effect of antipsychotic agents
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the CNS depressant effect
may enhance the CNS depressant effect
may enhance the CNS depressant effect
may enhance the CNS depressant effect
may enhance the tachycardic effect
may enhance the tachycardic effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
nafcillin will decrease the effect of action of tiagabine by affecting enzyme CYP3A4 metabolism.
the effect of tiagabine is decreased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism
antiseizure agents may diminish the diagnostic effect of metyrapone
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may increase the toxic effect of CNS depressants
- may increase the toxic effect of antipsychotic agents
may increase the toxic effect of CNS depressants
may increase the toxic effect of other CNS Depressants
may have an increased CNS depressant effect when combined with CNS depressants
may increase the toxic effect of Antipsychotic Agents
CNS depressants increase the CNS depressing effect of brexanolone
it increases the effect of CNS depressants
ixabepilone: they may increase the CNS depressant effect of CNS Depressants
may increase the serotonergic effects
may increase the serotonergic effects
may increase the serotonergic effects
may increase the serotonergic effects
may have an increased Effect of a CNS depressant when combined with CNS depressants
it increases the toxicity of CNS depressants
CNS depressants increase the effect of sedation of pramipexole
kava: they may increase the CNS depressant effect of CNS Depressants
levothyroxine: they may increase the CNS depressant effect of CNS Depressants
perampanel: they may increase the CNS depressant effect of CNS Depressants
it increases the effect of CNS depressants
CNS depressants increase the effect of buprenorphine
it increases the effect of CNS depressants
it increases the effect of CNS depressants
CNS depressants increase the effect of suvorexant
>10%:
Dizziness
Asthenia
Somnolence
Nausea
1-10%:
Abdominal pain
Diarrhea
Vomiting
Nervousness
Pharyngitis
Tremor
Insomnia
Rash
Pruritis
Ataxia
Confusion
Speech disorder
Paresthesia
Depression
Pain
Increased appetite
Hostility
Nystagmus
Tiagabine is contraindicated in patients hypersensitive to the formulation’s active ingredient and other excipients.
Pregnancy consideration:
Category C